Evidence map›Paper›PMID 40006601›Full record

ArticlePharmaceutics2025

CLEC3A-Derived Antimicrobial Peptides Reduce

Denise Meinberger, Gabriele Hermes, Bent Brachvogel, Gerhard Sengle, Dzemal Elezagic, Annika Roth, Johannes Ruthard, Thomas Streichert, Andreas R Klatt

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. CLEC3A-derived peptides exhibit broad-spectrum activity againstFrontiers in cellular and infection microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Denise MeinbergerInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Gabriele HermesInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Bent BrachvogelDepartment of Pediatrics and Adolescent Medicine, Experimental Neonatology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Gerhard SengleCenter for Biochemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0003-3932-1242
Dzemal ElezagicInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0003-1041-8470
Annika RothInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0002-3376-0968
Johannes RuthardInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Thomas StreichertInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0002-6588-720X
Andreas R KlattInstitute for Clinical Chemistry, Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.ORCID 0000-0002-8517-7512

Funding

Deutsche Forschungsgemeinschaft 384170921Deutsche Forschungsgemeinschaft 527884186
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial peptidesbiomaterial-associated infection modelCLEC3AC type lectinin vivo mouse modelpeptide modification

Identifiers

PMID40006601
PMCPMC11859532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.